Abstract
There is no consensus about the necessity and the possibility of therapy in primary sclerosing cholangitis. In some patients rapid deterioration of liver function may occur due to recurrent cholangitis and cholestasis. In one such patient, we obtained radiological evidence that the cholestasis was caused, not entirely by end-stage fibrotic scarring as interpreted upon surgical exploration, but, at least in part, by biliary stasis secondary to marked irregular narrowing of the extrahepatic bile ducts, together with precipitate formation. Moreover, the biliary ductular narrowing appeared to be partly reversible, indicating that edema and inflammation were responsible for part of the narrowing. These observations prompted us to evaluate topical lavage by nasobiliary drainage, first with saline, and then followed by corticosteroid solution in eight consecutive patients with recurrent cholangitis. Based upon clinical and biochemical evaluation, our preliminary results may be summarized as favorable. However, a large-scale multicenter controlled study will be required to prove the usefulness of this approach.
Similar content being viewed by others
References
Wiesner RH, LaRusso NT: Clinicopathologic features of the syndrome of primary sclerosering cholangitis. Gastroenterology 279:200–206, 1980
Chapman RWG, Narborgh BA, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ, Sherlock S: Primary sclerosering cholangitis: A review of its clinical features cholangiography and hepatic histology. Gut 21:870–877, 1980
Warren KW, Athanassiales S, Monge JM: Primary sclerosering cholangitis. Am J Surg 111:23–38, 1966
Brantigan CO, Brantigan OC: Primary sclerosering cholangitis and review of the literature. Am Surg 39:191–198, 1973
Dew MJ, Thompson H, Allan RN: The spectrum of hepatic dysfunction in inflammatory bowel disease. Q J Med 48:113–135, 1979
Schrumpf E, Elgio K, Fausa O: Sclerosering cholangitis in ulcerative colitis. Scand J Gastroenterol 15:689–697, 1980
Blackstone MO, Nemchausky BA: Cholangiographic abnormalities in ulcerative colitis associated pericholangitis which resemble sclerosering cholangitis. Am J Dig Dis 23:579–585, 1978
Spoelstra P: Leiden, personal communication.
Tinckler L: Primary sclerosering cholangitis. Postgrad Med J 47:666–670, 1971
Brown BP, LaBrecque DR, Anuras S: Response of sclerosering cholangitis to long-term steroid therapy. Gastroenterology 80:1117, 1981 (abstract)
Ludwig J, Barlam SS, LaRusso NF, Elveback LR, Wiesner RH, McCall JS: Morphologic features of chronic hepatitis associated with primary sclerosering cholangitis and chronic ulcerative colitis. Hepatology 1:632–640, 1981
Berge Henegouwen, van GP, Brandt KH, Bronkhorst FB, Heyde vd MN: Results of examination and treatment of patients with primary sclerosering cholangitis. Ned T Geneesk 126:1447–1452, 1982
Bodenheimer HC, LaRusso NF, Thayer WR: Elevated circulating immunes complexes in primary sclerosering cholangitis. Hepatology 3:150–154, 1983
Chapman RWG, Burroughs AK, Sherlock S: Long-standing asymptomatic primary sclerosering cholangitis. Dig Dis Sc 26:778–782, 1981
Wood RAB, Cuschieri A: Is sclerosering cholangitis complicating ulcerative colitis a reversible condition. Lancet 2:716–718, 1980
Huibregtse K, Tytgat GN: Palliative treatment of obstructive jaundice by transpapillary introduction of large bore bile duct endoprosthesis. Gut 23:371–375, 1982
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Grijm, R., Huibregtse, K., Bartelsman, J. et al. Therapeutic investigations in primary sclerosing cholangitis. Digest Dis Sci 31, 792–798 (1986). https://doi.org/10.1007/BF01296045
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01296045